MARLBOROUGH, Mass.-- (BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced the granting of a CE Mark to the LOCalizerâ„¢ wireless radio frequency identification (RFID) breast lesion localization ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, No. 42 (October 16, 2018), pp. 10792-10797 (6 pages) Our perception of free will is composed of a desire to ...
NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery of stage 1, HR+, HER2-, RS ≤18 breast cancer. This is an ASCO Meeting Abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback